SE7703786L - Triazolo-pyrimidiner och farmaceutiska kompositioner innehallande sadana foreningar - Google Patents

Triazolo-pyrimidiner och farmaceutiska kompositioner innehallande sadana foreningar

Info

Publication number
SE7703786L
SE7703786L SE7703786A SE7703786A SE7703786L SE 7703786 L SE7703786 L SE 7703786L SE 7703786 A SE7703786 A SE 7703786A SE 7703786 A SE7703786 A SE 7703786A SE 7703786 L SE7703786 L SE 7703786L
Authority
SE
Sweden
Prior art keywords
triazolo
pyrimidines
associations
pharmaceutical compositions
compositions containing
Prior art date
Application number
SE7703786A
Other languages
English (en)
Swedish (sv)
Inventor
A K Ganguly
E A Peets
A K Saksena
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of SE7703786L publication Critical patent/SE7703786L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7703786A 1976-04-05 1977-03-31 Triazolo-pyrimidiner och farmaceutiska kompositioner innehallande sadana foreningar SE7703786L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67378576A 1976-04-05 1976-04-05

Publications (1)

Publication Number Publication Date
SE7703786L true SE7703786L (sv) 1977-10-06

Family

ID=24704115

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7703787A SE7703787L (sv) 1976-04-05 1977-03-31 Trizzolo-pyrimidiner
SE7703786A SE7703786L (sv) 1976-04-05 1977-03-31 Triazolo-pyrimidiner och farmaceutiska kompositioner innehallande sadana foreningar

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7703787A SE7703787L (sv) 1976-04-05 1977-03-31 Trizzolo-pyrimidiner

Country Status (10)

Country Link
US (1) US4076711A (xx)
JP (2) JPS52122632A (xx)
AU (2) AU2384177A (xx)
BE (2) BE853085A (xx)
DE (2) DE2714254A1 (xx)
DK (2) DK146077A (xx)
FR (2) FR2347367A1 (xx)
NL (2) NL7703515A (xx)
SE (2) SE7703787L (xx)
ZA (2) ZA771998B (xx)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172829A (en) * 1978-05-09 1979-10-30 Bristol-Myers Company 2,9-Disubstituted adenine derivatives and their use as non-adrenergic bronchodilators
US4742064A (en) * 1985-09-10 1988-05-03 Regents Of The University Of Minnesota Antiviral carbocyclic analogs of xylofuranosylpurines
LU86547A1 (fr) * 1986-08-07 1988-03-02 Oreal Suspension pour induire et stimuler la croissance des cheveux et diminuer leur chute a base de derives de la pyrimidine
US5204353A (en) * 1987-04-07 1993-04-20 Ciba-Geigy Corporation 3-benzyl-3H-1,2,3-triazolo[4,5-d]pyrimidines, compositions thereof, and method of treating epilepsy therewith
ES2051886T3 (es) * 1987-04-07 1994-07-01 Ciba Geigy Ag Procedimiento para la obtencion de nuevos derivados de la 3h-1,2,3-triazolo(4,5-d)pirimidina.
US4916224A (en) * 1988-01-20 1990-04-10 Regents Of The University Of Minnesota Dideoxycarbocyclic nucleosides
US4950758A (en) * 1988-01-20 1990-08-21 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
US4931559A (en) * 1988-01-20 1990-06-05 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
US5631370A (en) * 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
US5175292A (en) * 1988-01-20 1992-12-29 Regents Of The University Of Minnesota Intermediates for the preparation of dideoxycarbocyclic nucleosides
US4996116A (en) * 1989-12-21 1991-02-26 General Electric Company Enhanced direct bond structure
US5514688A (en) * 1990-09-14 1996-05-07 Merrell Dow Pharmaceuticals Inc. Carbocyclic adenosine analogs useful as immunosuppressants
US5244896A (en) * 1990-09-14 1993-09-14 Marion Merrell Dow Inc. Carbocyclic adenosine analogs useful as immunosuppressants
CA2051012C (en) * 1990-09-14 2002-04-02 David R. Borcherding Carbocyclic adenosine analogs useful as immunosupressants
US5817661A (en) * 1991-12-06 1998-10-06 Hoechst Marion Roussel, Inc. Trans cyclopentanyl purine analogs useful as immunosuppressants
AU658698B2 (en) * 1991-12-06 1995-04-27 Aventis Pharmaceuticals Inc. Novel trans cyclopentanyl purine analogs useful as immunosuppressants
US5817672A (en) * 1991-12-06 1998-10-06 Hoechst Marion Roussel, Inc. Trans cyclopentanyl purine analogs useful as immunosuppressants
US5723466A (en) * 1991-12-06 1998-03-03 Hoechst Marion Roussel, Inc. Trans cyclopentanyl purine analogs useful as immunosuppressants
US5817660A (en) * 1991-12-06 1998-10-06 Hoechst Marion Roussel, Inc. Trans cyclopentanyl purine analogs useful as immunosuppressants
NZ331647A (en) * 1996-03-26 2000-03-27 Du Pont Pharm Co Aryloxy- and arylthio-fused pyridines and pyrimidines and derivatives
ZA971896B (en) 1996-03-26 1998-09-07 Du Pont Merck Pharma Aryloxy-and arythio-fused pyridines and pyrimidines and derivatives
ZA972497B (en) 1996-03-27 1998-09-25 Du Pont Merck Pharma Arylamino fused pyridines and pyrimidines
US6107300A (en) * 1996-03-27 2000-08-22 Dupont Pharmaceuticals Arylamino fused pyrimidines
US5858694A (en) * 1997-05-30 1999-01-12 Cell Pathways, Inc. Method for identifying compounds for inhibition of cancerous lesions
CA2238283C (en) 1997-05-30 2002-08-20 Cell Pathways, Inc. Method for identifying compounds for inhibition of neoplastic lesions, pharmaceutical compositions from such compounds and uses of such compounds and compositions for treating neoplastic lesions
US6410584B1 (en) * 1998-01-14 2002-06-25 Cell Pathways, Inc. Method for inhibiting neoplastic cells with indole derivatives
DE19838705A1 (de) 1998-08-26 2000-03-02 Bayer Ag Neue Dihydro-(1,2,3)-triazolo-[4,5-d]pyrimidin-7-one
US6200771B1 (en) 1998-10-15 2001-03-13 Cell Pathways, Inc. Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia
US6130053A (en) * 1999-08-03 2000-10-10 Cell Pathways, Inc. Method for selecting compounds for inhibition of neoplastic lesions
US6133271A (en) * 1998-11-19 2000-10-17 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives
US6187779B1 (en) 1998-11-20 2001-02-13 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to 2,8-disubstituted quinazoline derivatives
US6369092B1 (en) 1998-11-23 2002-04-09 Cell Pathways, Inc. Method for treating neoplasia by exposure to substituted benzimidazole derivatives
US6486155B1 (en) 1998-11-24 2002-11-26 Cell Pathways Inc Method of inhibiting neoplastic cells with isoquinoline derivatives
US6077842A (en) * 1998-11-24 2000-06-20 Cell Pathways, Inc. Method of inhibiting neoplastic cells with pyrazolopyridylpyridazinone derivatives
US6034099A (en) * 1998-11-24 2000-03-07 Cell Pathways, Inc. Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones
US6025394A (en) 1999-01-29 2000-02-15 Cell Pathways, Inc. Method for treating patients with acne by administering substituted sulfonyl indenyl acetic acids, amides and alcohols
US6020379A (en) * 1999-02-19 2000-02-01 Cell Pathways, Inc. Position 7 substituted indenyl-3-acetic acid derivatives and amides thereof for the treatment of neoplasia
US6555547B1 (en) 2000-02-28 2003-04-29 Cell Pathways, Inc. Method for treating a patient with neoplasia by treatment with a vinca alkaloid derivative
US6569638B1 (en) 2000-03-03 2003-05-27 Cell Pathways, Inc Method for screening compounds for the treatment of neoplasia
EP1703668A1 (en) * 2005-03-18 2006-09-20 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO System for processing quality-of-service parameters in a communication network
CN101438288A (zh) * 2006-03-15 2009-05-20 Csir公司 谷氨酰胺合成酶的磷酰基转移酶活性的调节
GB2451594A (en) * 2006-03-15 2009-02-04 Csir Modulation of phosphoryl transferase activity of glutamine synthetase
US8148385B2 (en) 2006-10-31 2012-04-03 Janssen Pharmaceutica N.V. Substituted [1,2,3] triazolo[4,5-d]pyrimidine derivatives as ADP P2Y12 receptor antagonists
WO2008054795A2 (en) * 2006-10-31 2008-05-08 Janssen Pharmaceutica, N.V. Triazolopyrimidine derivatives as adp p2y12 receptor antagonists
JP4927502B2 (ja) * 2006-11-08 2012-05-09 東京電力株式会社 ケーブル拘束装置
UA111640C2 (uk) * 2011-11-08 2016-05-25 Ф. Хоффманн-Ля Рош Аг ПОХІДНІ [1,2,3]ТРИАЗОЛО[4,5-d]ПІРИМІДИНУ ЯК АГОНІСТИ КАНАБІНОЇДНОГО РЕЦЕПТОРА 2
EP3505171A4 (en) 2016-08-26 2020-08-26 Mitsubishi Tanabe Pharma Corporation BICYCLIC NITROGENATED HETEROCYCLIC COMPOUND

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2407204A (en) * 1944-07-22 1946-09-03 American Cyanamid Co Triazolo (d) pyrimidines and methods of preparing the same

Also Published As

Publication number Publication date
BE853085A (fr) 1977-09-30
US4076711A (en) 1978-02-28
DK146677A (da) 1977-10-06
DE2714263A1 (de) 1977-10-13
AU2384277A (en) 1978-10-05
NL7703515A (nl) 1977-10-07
SE7703787L (sv) 1977-10-06
DE2714254A1 (de) 1977-10-06
JPS52122632A (en) 1977-10-15
JPS52122395A (en) 1977-10-14
FR2347367A1 (fr) 1977-11-04
NL7703514A (nl) 1977-10-07
BE853086A (fr) 1977-09-30
ZA771998B (en) 1978-03-29
FR2347044A1 (fr) 1977-11-04
DK146077A (da) 1977-10-06
AU2384177A (en) 1978-10-12
ZA771997B (en) 1978-03-29

Similar Documents

Publication Publication Date Title
SE7703786L (sv) Triazolo-pyrimidiner och farmaceutiska kompositioner innehallande sadana foreningar
SE420107B (sv) Kompositflamsprutningspulver och anvendning av detsamma
FI783917A (fi) Aminderivat deras framstaellningsfoerfarande och dessa innehaollande farmaceutiska kompositioner
SE7614050L (sv) Behallare och bricka
MX9203380A (es) Derivados de carbazolil-(4)-oxi-propanolamina y composiciones farmaceuticas que los contienen.
IT8024545A0 (it) Composizioni farmaceutiche topiche contenenti trietilenetetramina eloro metodi di impiego.
FI792009A (fi) 3-aminopropoxiarylderivat deras framstaellning och dessa innehaollande farmaceutiska sammansaettningar
IT7925182A0 (it) Derivati di spiro-ossazolidindioni e composizioni farmaceutiche che li contengono.
FI802437A (fi) 3-aminopropoxiarylderivat framstaellning av dem och farmaceutiska kompositioner innehaollande dem
SE7711395L (sv) Farmaceutisk komposition
NZ183134A (en) I-i-(3-aryloxy-2-hydroxypropyl)-4-piperidyl-3-aryl-imid-azolidin or hexahydropyrimidin-2-ones; and pharmaceutical compositions
SE7805642L (sv) Metylmetioninsulfoniumforeningar, forfarande for framstellning derav och farmaceutiska kompositioner innehallande dessa
SE7810142L (sv) Nya tiopropionamider och sett att framstella desamma samt farmaceutiska kompositioner, innehallande foreningarna
BE841797A (fr) Compositions photosensibles et leur application
SE7708265L (sv) Ny farmaceutisk komposition och forfarande for dess framstellning
DK461579A (da) Farmeceutisk komposition indeholdende en aryltrifluorethanol
SE7707369L (sv) Nya metaaminofenoler och fergkompositioner innehallande dessa metaaminofenoler
FR2326189A2 (fr) Composition pharmaceutique
FI803483L (fi) Makrolidantibiotika foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska kompositioner
SE7705658L (sv) Farmaceutisk komposition
SE7607241L (sv) Aralifatiska dihalogenforeningar och forfarande for framstellning derav
FI793848A (fi) Benzoxadiazoler och benzothiadiazoler deras framstaellning och farmaceutiska kompositioner innehaollande dessa
SE7505861L (sv) Antimikrobiella foreningar och kompositioner, innehallande sadana
FI792977A (fi) Nya tetracykliska foereningar foerfarande foer framstaellning av dem och farmaceutiska kompositioner
SE8001100L (sv) Beta-laktamforeningar